DRUG · Unmapped registry intervention
AMG 355
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NCT06131398
Study summary
ClinicalTrials.govA Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Pembrolizumab
Normalized identity: pembrolizumab View linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Advanced Solid Tumorsunresolved
Interventions
AMG 355DRUG
PembrolizumabDRUG · verified · RxNorm: pembrolizumab
Sponsors & collaborators
Amgenlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06131398 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.